X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-announces-fda-approval-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-for-the-treatment-of-presbyopia-301959581.html
https://endpts.com/after-cutting-back-on-vuity-last-fall-abbvie-culls-a-second-gen-presbyopia-eye-drop/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-pilocarpine-hydrochloride-ophthalmic-solution-38318.pdf
https://www.asiaone.com/business/arctic-vision-announces-first-patient-enrolled-phase-iii-clinical-trial-arvn003-presbyopia
https://www.prnewswire.com/news-releases/allergan-an-abbvie-company-announces-positive-topline-phase-3-results-evaluating-investigational-twice-daily-administration-of-vuity-pilocarpine-hci-ophthalmic-solution-1-25-in-adults-with-age-related-blurry-near-vision-pre-301517329.html
https://www.prnewswire.com/news-releases/vuity-pilocarpine-hci-ophthalmic-solution-1-25-the-first-and-only-fda-approved-eye-drop-to-treat-age-related-blurry-near-vision-presbyopia-is-now-available-301441253.html
https://www.fiercepharma.com/drug-delivery/abbvie-s-vuity-snags-fda-approval-as-first-eye-drop-for-presbyopia-rival-eyenovia
https://endpts.com/abbvie-lands-fda-approval-for-allergans-blurred-vision-eye-drop/
https://www.prnewswire.com/news-releases/us-food-and-drug-administration-approves-vuity-pilocarpine-hci-ophthalmic-solution-1-25-the-first-and-only-eye-drop-to-treat-presbyopia-age-related-blurry-near-vision-301412259.html
https://www.clinicaltrialsarena.com/news/allergan-solution-presbyopia-trials/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214193
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212377
https://www.prnewswire.com/news-releases/advanz-pharma-corp-acquires-international-rights-to-two-medicines-300821542.html
https://www.pharmacompass.com/pdf/news/stokes-healthcare-inc-issues-voluntary-nationwide-recall-of-pilocarpine-01-ophthalmic-solution-1552626536.pdf
https://www.fiercebiotech.com/biotech/dermavant-hires-cso-from-glaxosmithkline-buys-excessive-sweating-drug
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204398
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-May-3-2017-1493786253.pdf
https://globenewswire.com/news-release/2016/11/15/890096/0/en/Ganaxolone-and-Diazepam-Administered-Intravenously-Synergistically-Block-Seizures-in-Animal-Model-of-Status-Epilepticus.html
Market Place
Share 
